Eli Lilly to acquire Centessa in deal for treatment of sleep-wake disorders
MLex Summary: Eli Lilly and Co. has agreed to acquire Centessa Pharmaceuticals plc in a deal that aims "to advance treatments for sleep-wake disorders." Lilly is paying approximately $6.3 billion, or $38...To view the full article, register now.
Already a subscriber? Click here to view full article